<DOC>
	<DOCNO>NCT02653599</DOCNO>
	<brief_summary>This trial multi-center , randomize , double-blind , placebo-controlled parallel group , Phase 2 study subject Type 2 diabetes mellitus stable dose metformin evaluate safety efficacy TTP273 versus placebo glucose control body weight follow administration 3 month .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy TTP273 12 Weeks Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>The subject 6 month diagnosis Type 2 diabetes mellitus prior screen meet American Diabetes Association ( ADA ) guideline Type 2 diabetes mellitus . On stable regimen metformin monotherapy equivalent least 1000 mg/day last 3 month prior screen . Males . Females nonchildbearing potential . Generally stable health without history major surgery significant injury within last year without active infection . Diagnosis Type 1 diabetes mellitus , maturityonset diabetes young , insulinrequiring Type 2 Diabetes , unusual rare form diabetes mellitus , history diabetic ketoacidosis . Participation clinical trial receipt investigational product within 30 day . Participation formal weight loss program , fluctuation &gt; 5 % body weight , receive medication approve weight loss within 3 month prior screen contemplate therapy trial . Previous surgical treatment obesity . Have history hypoglycemic episode require glucose , glucagon , orange juice administer someone patient within 6 month prior screen . Use diabetic agent except metformin within 3 month prior Screening . History pancreatitis . Blood donation approximately 1 pint ( 500 mL ) within 8 week prior screen . History hemolytic anemia , chronic transfusion requirement condition render HbA1c result unreliable . History MEN2 family history medullary thyroid cancer . History presence clinically significant disease ( Type 2 diabetes mellitus ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>